Evaluation of the cardiac amyloidosis clinical pathway implementation: a real-world experience

AIMS: The aim of this study is to evaluate the implementation of the cardiac amyloidosis (CA) clinical pathway on awareness among referring cardiologists, diagnostic delay, and severity of CA at diagnosis. METHODS AND RESULTS: Patients with CA were retrospectively included in this study and divided...

Descripción completa

Detalles Bibliográficos
Autores principales: Brons, Maaike, Muller, Steven A, Rutten, Frans H, van der Meer, Manon G, Vrancken, Alexander F J E, Minnema, Monique C, Baas, Annette F, Asselbergs, Folkert W, Oerlemans, Marish I F J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242028/
https://www.ncbi.nlm.nih.gov/pubmed/35919127
http://dx.doi.org/10.1093/ehjopen/oeac011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242028/
https://www.ncbi.nlm.nih.gov/pubmed/35919127
http://dx.doi.org/10.1093/ehjopen/oeac011

Ejemplares similares